Skip to main content
SpringerLink
Log in

Fibrinolysis

  • Chapter
Book cover The Peritoneum

  • 133 Accesses

Abstract

Fibrinolysis, which represents the end stage of coagulation, was defined by Dastre in 1893 as the dissolution of polymerized fibrin. Todd (1959) reported the presence of fibrinolytic activity in serosal cells derived from human peritoneum and pleura. Astrup and Allbrechtsen (1957) demonstrated plasminogen activator in extracts of serosa from the human fallopian tube and parietal peritoneum of the rat uterus. These studies were confirmed by others who demonstrated fibrinolytic activity and plasminogen activator in parietal pleura, pericardium, and peritoneum (Myhre-Jensen, Larsen, & Astrup, 1969; Porter, McGregor, Mullen, & Silver, 1969; Porter, Ball, & Silver, 1971; Raftery, 1979; Merlo, Fausone, Barbero, & Castagna, 1980). Pugatch and Poole (1969) subsequently reported the presence of fibrinolysis-inhibiting agents in bovine parietal peritoneum. Plasmin, the major enzyme involved in fibrinolysis, is formed from the inactive precursor, plasminogen, by the action of plasminogen activators (PA). PAs are found in urine, tissues, and blood. Normally, coagulation and fibrinolysis are in balance such that no net fibrin deposition occurs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abe H, Rodgers KE, Campeau JD, Girgis W, Ellefson D, diZerega GS. (1990). The effect of intraperitoneal administration of sodium tolmetin-hyaluronic acid on the postsurgical cell infiltration in vivo. J Surg Res. 49: 322–327.

    Article  PubMed  CAS  Google Scholar 

  • Albrechtsen OK. (1956). The fibrinolytic activity of the human endometrium. Acta Endocrinol 23: 207–218.

    PubMed  CAS  Google Scholar 

  • Albrechtsen OK. (1957a). The fibrinolytic activity of human tissues. Br J Haematol 3: 284–291.

    Article  PubMed  CAS  Google Scholar 

  • Albrechtsen OK. (1957b). The fibrinolytic activity of animal tissues. Acta Physiol Scand. 39: 284–290.

    Article  PubMed  CAS  Google Scholar 

  • Andersson L, Nilsson IM, Olow B. (1962). Fibrinolytic activity in man during surgery. Thromb Diath Haemorrh. 7: 392–403.

    Google Scholar 

  • Andersson L. (1964). Antifibrinolytic treatment with epsilon-amino-caproic acid in connection with prostatectomy. Acta Chir Scand. 127: 552–559.

    PubMed  CAS  Google Scholar 

  • Astrup T, Albrechtsen OK. (1957). Estimation of the plasminogen activator and the trypsin inhibitor in animal and human tissues. Scand J Clin Lab Invest. 9: 233–243.

    Article  PubMed  CAS  Google Scholar 

  • Astrup T, Albrechtsen OK, Claassen M, Rasmussen J. (1959). Thromboplastic and fibrinolytic activity of human aorta. Circ Res. 7: 969–974.

    PubMed  CAS  Google Scholar 

  • Astrup T, Claassen M. (1957). Fibrinolytic activity of the peritoneum. Trans. 6th Congr. European Soc. Haematol., Copenhagen. Basel; Karger; 455–459.

    Google Scholar 

  • Bauer KA, ten Cate H, Barzegar S, Spriggs DR, Sherman ML, Rosenberg RD. (1989). Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans. Blood. 74: 165–177.

    PubMed  CAS  Google Scholar 

  • Booth NA, Anderson JA, Bennett B. (1985). Platelet release protein which inhibits plasminogen activators. J Clin Pathol. 38: 825–830.

    Article  PubMed  CAS  Google Scholar 

  • Brandtzaeg P, Joo GB, Brusletto B, Kierulf P. (1990). Plasminogen activator inhibitor 1 and 2, α2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease. Thromb Res. 57: 271–275.

    Article  PubMed  CAS  Google Scholar 

  • Britton BJ, Giddings JC, Brooks L, Bloom AL. (1977). Fibrinolytic, factor VIII and pulse rate responses to repeated adrenaline infusion followed by haemorrhagia. Thromb Haemost. 37: 527–534.

    PubMed  CAS  Google Scholar 

  • Buckman RF Jr., Maj MC, Buckman PD, Hufnagel HV, Gervin AS. (1976). A physiologic basis for the adhesion-free healing of deperitonealized surfaces. J Surg Res. 21: 67–76.

    Article  PubMed  Google Scholar 

  • Chakrabarti R, Hocking ED, Fearnley GR. (1969). Reaction pattern to three stresses—electroplexy, surgery and myocardial infarction—of fibrinolysis and plasma fibrinogen. J Clin Pathol. 22: 659–662.

    Article  PubMed  CAS  Google Scholar 

  • Chapman HA Jr, Stone OL, Vavrin Z. (1984). Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation. J Clin Invest. 73: 806–815.

    Article  PubMed  CAS  Google Scholar 

  • Coccheri S, Astrup T. (1961). Thromboplastic and fibrinolytic activities of large human vessels. Proc Soc Exp Biol Med. 108: 369–372.

    PubMed  CAS  Google Scholar 

  • Dastre A. (1893). Fibrinolyse dans le sang. Arch Physiol Norm Pathol. 5: 661–663.

    Google Scholar 

  • Deutsch DG, Mertz ET. (1970). Plasminogen purification from human plasma by affinity chromatography. Science. 170: 1095–1096.

    Article  PubMed  CAS  Google Scholar 

  • Donse AM, Dupuy E, Bodevin E. (1978). Production of a fibrinolytic inhibitor by cultured endothelial cells derived from human umbilical vein. Thromb Res. 12: 377–387.

    Article  Google Scholar 

  • Doody KJ, Dunn RC, Buttram VC. (1989). Recombinant tissue plasminogen activator reduces adhesion formation in a rabbit uterine horn model. Fertil Steril. 51: 509–512.

    PubMed  CAS  Google Scholar 

  • Ellis H, Harrison W, Hugh TB. (1965). The healing of peritoneum under normal and pathologic conditions. Br J Surg. 52: 471–476.

    Article  PubMed  CAS  Google Scholar 

  • Emeis JJ, Van Hinsbergh VWM, Verheijen JH, Wijngaards G. (1983). Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cells. Biochem Biophys Res Commun. 110: 392–398.

    Article  PubMed  CAS  Google Scholar 

  • Ende N, Auditore J. (1961). Fibrinolytic activity of human tissues and dog mast cell tumors. Am J Clin Pathol 36: 16–24.

    PubMed  CAS  Google Scholar 

  • Engqvist A, Winther O. (1972). Variations of plasma Cortisol and blood fibrinolytic activity during anaesthetic and surgical stress. Br J Anaesth. 44: 1291–1297.

    Article  Google Scholar 

  • Erickson LA, Ginsberg MH, Loskutoff DJ. (1984). Detection and partial characterization of an inhibitor of plasminogen activator in human platelets. J Clin Invest. 74: 1465–1472.

    Article  PubMed  CAS  Google Scholar 

  • Esnard F, Dupuy E, Dosne AM, Bodevin E. (1982). Partial characterization of a fibrinolytic inhibitor produced by cultured endothelial cells derived from human umbilical vein. Thromb Haemost. 47: 128–131.

    PubMed  CAS  Google Scholar 

  • Fukasawa M, Campeau JD, Girgis W, Bryant SW, Rodgers KE, diZerega GS. (1989). Production of protease inhibitors by postsurgical macrophages. J Surg Res. 46: 256–261.

    Article  PubMed  CAS  Google Scholar 

  • Gervin AS, Puckett CL, Silver D. (1973). Serosal hypofibrinolysis. A cause of postoperative adhesions. Am J Surg. 125: 80–88.

    Article  PubMed  CAS  Google Scholar 

  • Grossbard EB. (1987). Recombinant tissue plasminogen activator: a brief review. Pharmacol Res. 4: 375–378.

    Article  CAS  Google Scholar 

  • Hau T, Payne D, Simmons RL. (1979). Fibrinolytic activity of the peritoneum during experimental peritonitis. Surg Gynecol Obstet. 148: 415–418.

    PubMed  CAS  Google Scholar 

  • Hedlund PO. (1969). Antifibrinolytic therapy with cyklokapron in connection with prostatectomy. Scand J Urol Nephrol. 3: 177–182.

    Article  PubMed  CAS  Google Scholar 

  • Innes D, Sevitt S. (1974). Coagulation and fibrinolysis in injured patients. J Clin Pathol. 17: 1–13.

    Article  Google Scholar 

  • Jespersen J, Astrup TA. (1983). Study of the fibrin plate assay of fibrinolytic agents. Haemostasis. 13: 301–315.

    PubMed  CAS  Google Scholar 

  • Korsan-Bengtsen K, Wilhelmsen L, Tibblin G. (1973). Blood coagulation and fibrinolysis in relation to degree of physical activity during work and leisure time. Acta Med Scand. 193: 73–77.

    Article  PubMed  CAS  Google Scholar 

  • Kruithof EKO, Tran-Thang C, Ransijn A, Backmann F. (1984). Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. Blood. 64: 907–913.

    PubMed  CAS  Google Scholar 

  • Laug WE. (1985). Vascular smooth muscle cells inhibit plasminogen activator secreted by endothelial cells. Thromb Haemost. 53: 165–169.

    PubMed  CAS  Google Scholar 

  • Levin EG. (1983). Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex. Proc Natl Acad Sci USA. 80: 6804–6808.

    Article  PubMed  CAS  Google Scholar 

  • Loskutoff DJ, Van Mourik JA, Erickson LA, Lawrence D. (1983). Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells. Proc Natl Acad Sci USA. 80: 2956–2961.

    Article  PubMed  CAS  Google Scholar 

  • Macfarlane RG. (1937). Fibrinolysis following operation. Lancet. 1: 10.

    Article  Google Scholar 

  • Markwardt F, Klocking HP. (1977). Heparin-induced release of plasminogen activator. Haemostasis. 6: 370–374.

    PubMed  CAS  Google Scholar 

  • Mayer M, Yedgar S, Hurwitz A, Palti Z, Finzi Z, Milwidsky A. (1988). Effect of viscous macromolecules on peritoneal plasminogen activator activity: potential mechanism for their ability to reduce postoperative adhesion formation. Am J Obstet Gynecol. 159: 957–963.

    PubMed  CAS  Google Scholar 

  • Menzies D, Ellis H. (1989). Intra-abdominal adhesions and their prevention by topical tissue plasminogen activator. J R Soc Med. 82: 534–535.

    PubMed  CAS  Google Scholar 

  • Merlo G, Fausone G, Barbero C, Castagna B. (1980). Fibrinolytic activity of the human peritoneum. Eur Surg Res. 12: 433–438.

    Article  PubMed  CAS  Google Scholar 

  • Moroz LA, Gilmore NJ. (1976). Fibrinolysis in normal plasma and blood: evidence for significant mechanisms independent of the plasminogen-plasmin system. Blood. 48: 531–545.

    PubMed  CAS  Google Scholar 

  • Myhre-Jensen O, Larsen SB, Astrup T. (1969). Fibrinolytic activity in serosal and synovial membranes. Arch Pathol. 88: 623–630.

    Google Scholar 

  • Nilsson IM, Pandolfi M. (1970). Fibrinolytic response of the vascular wall. Thromb Diath Haemorrh Suppl. 40: 231–242.

    Google Scholar 

  • Ny T, Bjersing L, Hsuek AJW, Loskutoff DJ. (1985). Cultured granulosa cells produce two plasminogen activators and an antiactivator, each regulated differently by gonadotropins. Endocrinology. 116: 1666–1668.

    Article  PubMed  CAS  Google Scholar 

  • Orita H, Girgis W, diZerega GS. (1991). Inhibition of postsurgical adhesions in a standardized rabbit model: intraperitoneal administration of tissue plasminogen activator. Int J Fert. 36: 172–177.

    CAS  Google Scholar 

  • Philips M, Juul AG, Thorsen S. (1984). Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex. Biochim Biophys Acta. 802: 99–110.

    PubMed  CAS  Google Scholar 

  • Pike GJ, Turner RL, Manohitharajah SM, Deverall PB. (1975). Fibrinolysis in cyanotic and acyanotic children before and after open intracardiac operations with the Bentley temptrol oxygenator. J Thorac Cardivosc. Surg. 69: 922–926.

    CAS  Google Scholar 

  • Porter JM, McGregor FH, Mullen DC, Silver D. (1969). Fibrinolytic activity of mesothelial surfaces. Surg Forum. 20: 80–82.

    PubMed  CAS  Google Scholar 

  • Porter JM, Ball AP, Silver D. (1971). Mesothelial fibrinolysis. J Thorac Cardiovasc Surg. 62: 725–730.

    PubMed  CAS  Google Scholar 

  • Pugatch EM, Poole JC. (1969). Inhibitor of fibrinolysis from mesothelium. Nature. 221: 269–270.

    Article  PubMed  CAS  Google Scholar 

  • Raftery AT. (1979). Regeneration of peritoneum: a fibrinolytic study. J Anat. 129: 659–664.

    PubMed  CAS  Google Scholar 

  • Raftery AT. (1981a). Effect of peritoneal trauma on peritoneal fibrinolytic activity and intraperitoneal adhesion formation. Eur Surg Res. 13: 397–401.

    Article  PubMed  CAS  Google Scholar 

  • Raftery AT. (1981b). A method for measuring fibrinolytic activity in a single layer of cells. J Clin Pathol. 34: 625–629.

    Article  PubMed  CAS  Google Scholar 

  • Ratnoff OD. (1953). Studies on a proteolytic enzyme in human plasma. IX. Fibrinogen and fibrin as substrated for the proteolytic enzyme of plasma. J Clin Invest. 32: 473–479.

    Article  PubMed  CAS  Google Scholar 

  • Rennie JAN, Bennett B, Ogston D. (1977). Effect of local exercise and vessel occlusion on fibrinolytic activity. J Clin Pathol. 30: 350–352.

    Article  PubMed  CAS  Google Scholar 

  • Rodgers KE. (1990). Nonsteroidal anti-inflammatory drugs (NSAIDs) in the treatment of postsurgical adhesion. In: diZerega GS, Malinak LR, Diamond MD, Linsky CL, eds. Treatment of Postsurgical Adhesions (Progress in Clin Biol Res). New York: Wiley-Liss Press; 358: 119–130.

    Google Scholar 

  • Rodgers KE, Abe H, Campeau JD, Ellefson DD, Girgis W, diZerega GS. (in press). In vivo administration of tolmetin in hyaluronic acid modulates protease secretion by postsurgical macrophages. J Invest Surg.

    Google Scholar 

  • Ryan GB, Grobety J, Majno G. (1973). Mesothelial injury and recovery. Am J Pathol. 71: 93–112.

    PubMed  CAS  Google Scholar 

  • Silverman P, Goldsmith GH Jr., Spitzer TR, Rehmus EH, Berger NA. (1990). Effect of tumor necrosis factor on the human fibrinolytic system. J Clin Oncol. 8: 468–472.

    PubMed  CAS  Google Scholar 

  • Sprengers ED, Verheijen JH, Van Hinsbergh VWM, Emeis JJ. (1984). Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium. Biochim Biophys Acta. 801: 163–170.

    PubMed  CAS  Google Scholar 

  • Thorsen S, Philips M. (1984). Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor. Biochim Biophys Acta. 802: 111–118.

    PubMed  CAS  Google Scholar 

  • Todd AS. (1958). Fibrinolysis autographs. Nature. 181: 495–496.

    Article  PubMed  CAS  Google Scholar 

  • Todd AS. (1959). The histological localisation of fibrinolysis activator. J Pathol Bacteriol. 78: 281–283.

    Article  PubMed  CAS  Google Scholar 

  • Unkeless JC, Gordon S, Reich S. (1974). Secretion of plasminogen activator by stimulated macrophages. J Exp Med. 139: 834–850.

    Article  PubMed  CAS  Google Scholar 

  • van der Poll T, Levi M, Buller HR, van Deventer SJA, de Boer JP, Hack CE, ten Cate JW. (1991). Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med. 175: 729–732.

    Google Scholar 

  • van Hinsbergh VWM, Kooistra T, Scheffer MA, van Bockel JH, van Muijen GNP. (1990). Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood. 75:1490–1497.

    PubMed  Google Scholar 

  • Vipond MN, Whawell SA, Thompson JN, Dudley HAF. (1990). Peritoneal fi-brinolytic activity and intra-abdominal adhesions. Lancet. 335: 1120–1122.

    Article  PubMed  CAS  Google Scholar 

  • Wallenbeck IAM, Tangen O. (1975). On the lysis of fibrin formed in the presence of dextran and other macromolecules. Thromb Res. 6: 75–86.

    Article  PubMed  CAS  Google Scholar 

  • Whitaker D, Papadimitriou JM, Walters N-I. (1982). The mesothelium: its fibrinolytic properties. J Pathol. 136: 295–299.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medicine Livingston Research Center, University of Southern California, Los Angeles, CA, 90033, USA

    Gere S. diZerega M.D. (Professor of Obstetrics and Gynecology) & Kathleen E. Rodgers Ph.D. (Assistant Research Professor)

Authors
  1. Gere S. diZerega M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kathleen E. Rodgers Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin New York, Inc.

About this chapter

Cite this chapter

diZerega, G.S., Rodgers, K.E. (1992). Fibrinolysis. In: The Peritoneum. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-9235-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-9235-4_7

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4613-9237-8

  • Online ISBN: 978-1-4613-9235-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation